721 followers
#HealthEconJA Physicians’ attitude towards selection of second line therapy with nilotinib and dasatinib in chroni… https://t.co/Xi19xCv5wJ
#HealthEconJA Physicians’ attitude towards selection of second line therapy with nilotinib and dasatinib in chroni… https://t.co/Xi19xCv5wJ